Table 2.

Age and outcomes of patients with subacute sclerosing panencephalitis cases during pregnancy

	Time of delivery (gestational weeks)	Patient presentation	Treatment	Patient outcome	Child outcome
14 years16	33	Progressive confusion and visual loss	Interferon alfa (6 weeks)	Subacute sclerosing panencephalitis stage 4	Healthy at 5 months
15 years 38	Not reported	Confusion	None	Subacute sclerosing panencephalitis stage 4	Healthy at 3 years
15 years 39	30	Confusion	Not reported	Alive; subacute sclerosing panencephalitis stage not reported	Healthy infant
16 years 40	30	Progressive confusion and visual loss	None	Death	Death 4 days after birth
18 years 41	Last trimester	Confusion	None	Death	Healthy
18 years 42	Last trimester	Confusion	None	Death	Intrauterine death
19 years 43	36	Progressive confusion and visual loss	None	Death	Intrauterine death
19 years 39	30	Confusion	Not reported	Death	Healthy
19 years 43	38	Progressive confusion and visual loss	None	Death	Healthy at 5 years
20 years 44	26	Progressive confusion and visual loss	None	Death	Intrauterine death
20 years 43	Last trimester	Progressive confusion and visual loss	None	Death	Healthy
20 years 45	35	Confusion	Prednisone	Stabilised subacute sclerosing panencephalitis stage 4	Healthy at 15 months
20 years 46	40	Confusion and myoclonus	Interferon alfa-2b (5 weeks)	Death	Not reported
20 years 47	28	Progressive confusion and visual loss	Interferon alfa (6 weeks)	Stabilised subacute sclerosing panencephalitis stage 4	Healthy at 7 months
21 years 48	34	Confusion	None	Subacute sclerosing panencephalitis stage 4	Death within 24 h
21 years 49	31	Myoclonus	Isoprinosine	Death	Death at 3 years
24 years 42	Second month	Confusion	None	Death	Intrauterine death
27 years 41	33	Progressive confusion and visual loss	None	Stabilised subacute sclerosing panencephalitis stage 4	Healthy
29 years (patient described in this Grand Round)	31	Confusion	Plasmapheresis; intravenous immunoglobulin; rituximab	Death	Healthy at 1 year
34 years 50	40	Progressive confusion and visual loss	Interferon alfa-2b (6 weeks)	Stabilised subacute sclerosing panencephalitis stage 3	Healthy
Age not specified “young”2	33	Confusion	Methylprednisone; dexamethasone	Death	Healthy
Age not specified “young”51	Third trimester	Not reported	Not reported	Not reported	Not reported